Characteristics

Overall

Metastatic

Locally Advanced

Median Age

53.00 ± 10.787

50.62 ± 10.02

54.97 ± 11.06

Chemo duration

3 weekly

3 weekly

3 weekly

Pre-menopausal

20/65

11/26

9/39

Post-menopausal

45/65

15/26

30/39

HER2 by IHC 3+

45/65

17/26

28/39

HER2 (IHC 2+) confirmed by FISH

20/65

9/26

11/39

Hormonal status (ER, PR, HER2 neu)

Triple Positive

ER & PR negative, HER2 positive

31/65

34/65

9/26

17/26

22/39

17/39

Chemotherapy regimen

AC → Paclitaxel + Trastuzumab

TCH

30/65

35/65

15/26

13/26

25/39

22/39

Ki 67 > 20

Ki 67 < 20

64/65

1/65

26/26

1/26

38/39

0/39